MyAverix Finance
US · Healthcare
AEON Biopharma, Inc. (AEON)
Biotechnology
AEON Biopharma, Inc. (AEON) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AEON
AEON Biopharma, Inc. (AEON) — FAQ
What is AEON's P/E ratio?
The price-to-earnings (P/E) ratio for AEON Biopharma, Inc. (AEON) is 25.00 (data as of 2026-05-23).
Does AEON Biopharma, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for AEON Biopharma, Inc. (AEON). Check the MyAverix Finance app for the latest dividend data.
What sector is AEON Biopharma, Inc. in?
AEON Biopharma, Inc. (AEON) is classified in the Healthcare sector (Biotechnology industry).
What exchange is AEON listed on?
AEON is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.